Hjem
Anders Molvens bilde

Anders Molven

Professor
  • E-postAnders.Molven@uib.no
  • Telefon+47 55 97 31 69+47 480 21 044
  • Besøksadresse
    Avdeling for patologi, 2. etasje, Sentralblokken, Haukeland Universitets- sjukehus, Bergen
    Rom 
    5308
  • Postadresse
    Postboks 7804
    5020 Bergen
  • Pancreas-cancer (kreft i bukspyttkjertelen)
  • Arvelig diabetes (sukkersyke)
  • Arvelig hypoglykemi (lavt blodsukker)
  • Arvelig malignt melanom (føflekkreft)
Vitenskapelig artikkel
  • 2019. α11β1 integrin is induced in a subset of cancer- associated fibroblasts in desmoplastic tumor stroma and mediates in vitro cell migration. Cancers.
  • 2019. The hybrid allele 1 of carboxyl-ester lipase (CEL-HYB1) in Polish pediatric patients with chronic pancreatitis. Pancreatology (Print). 531-534.
  • 2019. Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma. BMC Cancer. 1-12.
  • 2019. Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes. The journal of pathology. Clinical research. 69-82.
  • 2019. Genome-wide association study reveals dynamic role of genetic variation in infant and early childhood growth. Nature Communications. 1-10.
  • 2018. The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants. Journal of Biological Chemistry. 19476-19491.
  • 2018. Telomere length and survival in primary cutaneous melanoma patients. Scientific Reports. 1-9.
  • 2018. Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes. Diabetes. 1297-1309.
  • 2017. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Biomarker Research.
  • 2017. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes. Diabetes Research and Clinical Practice. 142-149.
  • 2017. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. Diabetologia. 625-635.
  • 2017. Iris malformation and anterior segment dysgenesis in mice and humans with a mutation in PI 3-Kinase. Investigative Ophthalmology and Visual Science. 3100-3106.
  • 2017. Hypoglycemia and decreased insulin requirement caused by malignant insulinoma in a type 1 diabetic patient: when the hoof beats are from a zebra, not a horse. Clinical Case Reports. 761-768.
  • 2017. Heterogeneity of proliferative markers in pancreatic β-cells of patients with severe hypoglycemia following Roux-en-Y gastric bypass. Acta Diabetologica. 737-747.
  • 2017. Functional investigations of HNF1A identify rare variants as risk factors for type 2 diabetes in the general population. Diabetes. 335-346.
  • 2017. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nature Communications. 1-15.
  • 2017. Copy number variants and VNTR length polymorphisms of the carboxyl-ester lipase (CEL) gene as risk factors in pancreatic cancer. Pancreatology (Print). 83-88.
  • 2017. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Scientific Reports. 1-16.
  • 2017. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival. Cancer Medicine. 1531-1540.
  • 2016. The hypoglycemic phenotype is islet cell-autonomous in short-chain hydroxyacyl-CoA dehydrogenase-deficient mice. Diabetes. 1672-1678.
  • 2016. PI3-kinase mutation linked to insulin and growth factor resistance in vivo. Journal of Clinical Investigation. 1401-1412.
  • 2016. Length of variable numbers of tandem repeats in the carboxyl ester lipase (CEL) gene may confer susceptibility to alcoholic liver cirrhosis but not alcoholic chronic pancreatitis. PLOS ONE.
  • 2016. Branched Fatty Acid Esters of Hydroxy Fatty Acids Are Preferred Substrates of the MODY8 Protein Carboxyl Ester Lipase. Biochemistry. 4636-4641.
  • 2016. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Journal of Controlled Release. 172-181.
  • 2015. IGHV gene usage and mutational status in follicular lymphoma: Correlations with prognosis and patient age. Leukemia Research. 702-708.
  • 2015. Glycogenin-2 is dispensable for liver glycogen synthesis and glucagon-stimulated glucose release. Journal of Clinical Endocrinology and Metabolism. E767-E775.
  • 2015. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nature Genetics. 987-995.
  • 2015. Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. International Journal of Cancer. 1351-1360.
  • 2015. A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis. Nature Genetics. 518-522.
  • 2014. U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells . Cancer Medicine. 812-824.
  • 2014. The effect on melanoma risk of genes previously associated with telomere length. Journal of the National Cancer Institute.
  • 2014. Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma. Journal of Clinical Pathology. 1072-1077.
  • 2014. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nature Genetics. 357-363.
  • 2014. First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. PLOS ONE.
  • 2014. Endocytosis of secreted carboxyl ester lipase in a syndrome of diabetes and pancreatic exocrine dysfunction. Journal of Biological Chemistry. 29097-29111.
  • 2014. Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid. Diabetes. 259-269.
  • 2014. Assessment of Exocrine Pancreatic Function by Secretin-Stimulated Magnetic Resonance Cholangiopancreaticography and Diffusion-Weighted Imaging in Healthy Controls. Journal of Magnetic Resonance Imaging. 448-454.
  • 2013. Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 1037-1046.
  • 2013. Type 2 diabetes genes : present status and data from Norwegian studies. Norsk Epidemiologi. 9-22.
  • 2013. The number of tandem repeats in the carboxyl-ester lipase (CEL) gene as a risk factor in alcoholic and idiopathic chronic pancreatitis. Pancreatology (Print). 29-32.
  • 2013. Severe pancreatic dysfunction but compensated nutritional status in monogenic pancreatic disease caused by carboxyl-ester lipase mutations. Pancreas. 1078-1084.
  • 2013. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. American Journal of Human Genetics. 150-157.
  • 2013. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry. Diabetologia. 1512-1519.
  • 2013. Monogenetic diabetes mellitus in Norway :. Norsk Epidemiologi. 55-60.
  • 2013. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. Journal of Medical Genetics. 264-U82.
  • 2013. Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. Cancer Research. 7090-7100.
  • 2013. Exocrine pancreatic function in hepatocyte nuclear factor 1 beta-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Diabetic Medicine. 946-955.
  • 2013. Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nature Genetics. 1380-1385.
  • 2013. Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation. Melanoma research. 221-226.
  • 2013. Absence of diabetes and pancreatic exocrine dysfunction in a transgenic model of carboxyl-ester lipase-MODY (Maturity-Onset Diabetes of the young). PLOS ONE. 11 sider.
  • 2013. A variant in FTO shows association with melanoma risk not due to BMI. Nature Genetics. 428-432.
  • 2012. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas. Genes, Chromosomes and Cancer. 654-661.
  • 2012. HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease. Pediatric Diabetes. e1-e5.
  • 2012. GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1705-1715.
  • 2012. Familial occurrence of neonatal diabetes with duplications in chromosome 6q24: treatment with sulfonylurea and 40-yr follow-up. Pediatric Diabetes. 155-162.
  • 2012. Exome sequencing and genetic testing for MODY. PLOS ONE. 8 sider.
  • 2012. Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. PLOS ONE. 8 sider.
  • 2011. Visualization of CD44 and CD133 in Normal Pancreas and Pancreatic Ductal Adenocarcinomas: Non-overlapping Membrane Expression in Cell Populations Positive for Both Markers. Journal of Histochemistry and Cytochemistry. 441-455.
  • 2011. The role of pancreatic imaging in monogenic diabetes. Nature Reviews Endocrinology.
  • 2011. Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Experimental Cell Research. 234-247.
  • 2011. Genome-wide association study identifies three new melanoma susceptibility loci. Nature Genetics. 1108-U98.
  • 2011. FTO, type 2 diabetes, and weight gain throughout adult life A meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes. 1637-1644.
  • 2011. Evaluation of four novel genetic variants affecting hemoglobin A1c levels in a population-based type 2 diabetes cohort (the HUNT2 study). BMC Medical Genetics. 6 sider.
  • 2011. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. Journal of Medical Genetics. 825-830.
  • 2011. Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY) A PROTEIN MISFOLDING DISEASE. Journal of Biological Chemistry. 34593-34605.
  • 2011. Detection of clonality in follicular lymphoma using formalin-fixed, paraffin-embedded tissue samples and BIOMED-2 immunoglobulin primers. Journal of Clinical Pathology. 37-41.
  • 2010. Polygenic risk variants for Type 2 Diabetes susceptibility modify age at diagnosis in Monogenic HNF1A Diabetes. Diabetes. 266-271.
  • 2010. Pancreatic Function in Carboxyl-Ester Lipase Knockout Mice. Pancreatology (Print). 467-476.
  • 2010. Mutations in the VNTR of the carboxyl-ester lipase gene (CEL) are a rare cause of monogenic diabetes. Human Genetics. 55-64.
  • 2010. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proceedings of the National Academy of Sciences of the United States of America. 775-780.
  • 2010. Er formakogenetisk CYP2D6-testing nyttig? Tidsskrift for Den norske legeforening. 2224-2228.
  • 2010. Er farmakogenetisk CYP2D6-testing nyttig? Tidsskrift for Den norske legeforening. 2224-2228.
  • 2010. Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 antibodies. BMC Endocrine Disorders.
  • 2010. DNA hypomethylation, transient neonatal diabetes, and prune belly sequence in one of two identical twins. European Journal of Pediatrics. 207-213.
  • 2009. pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda. BMC Clinical Pathology.
  • 2009. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clinical Genetics. 440-448.
  • 2009. Mutasjonsdiagnostikk ved syndromer knyttet til RAS/MAPK-signalveien. Tidsskrift for Den norske legeforening. 2358-2361.
  • 2009. Lymphomas diagnosed in Uganda during the HIB/AIDS pandemic. East African Medical Journal. 226-32.
  • 2009. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue. Diagnostic molecular pathology (Print). 150-155.
  • 2009. Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia. Melanoma research. 119-122.
  • 2008. Wolcott-Rallison syndrome with 3-hydroxydicarboxylic aciduria and lethal outcome. Journal of Inherited Metabolic Disease.
  • 2008. Utredning og behandling av medfødt hyperinsulinisme (1): Molekylære og genetiske aspekter. Pediatrisk Endokrinologi. 37-43.
  • 2008. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. Journal of Clinical Endocrinology and Metabolism. 3505-3509.
  • 2008. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabetic Medicine. 775-781.
  • 2008. Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes, Chromosomes and Cancer. 175-184.
  • 2008. Pancreatic Exocrine Dysfunction in Maturity-Onset Diabetes of the Young Type 3. Diabetes Care. 306-310.
  • 2008. Neurological features and enzyme therapy in patients with endocrine and exocrine pancreas dysfunction due to CEL mutations. Diabetes Care. 1738-1740.
  • 2008. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes. 1131-1135.
  • 2008. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes. 1131-1135.
  • 2008. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma research. 29-35.
  • 2008. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabetic Medicine. 782-787.
  • 2008. Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia. 971-977.
  • 2008. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer. 14 sider.
  • 2008. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry. Pediatric Diabetes. 442-449.
  • 2008. Clinicopathological characteristics and non-adhesive organ culture of insulinomas. Scandinavian Journal of Surgery. 42-49.
  • 2008. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. International Journal of Cancer. 761-768.
  • 2008. Activating glucokinase (GCK) Mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. European Journal of Endocrinology. 27-34.
  • 2007. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians. Diabetes. 3112-3117.
  • 2007. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-Ester lipase. Diabetes. 444-449.
  • 2007. Distal phalangeal creases - A distinctive dysmorphic feature in disorders of the RAS signalling pathway? European Journal of Medical Genetics. 155-158.
  • 2007. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. Journal of Medical Genetics. 6 sider.
  • 2007. Biochemical and functional characterization of germ line KRAS mutations. Molecular and Cellular Biology. 7765-7770.
  • 2006. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nature Genetics. 54-62.
  • 2006. Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation. International Journal of Cancer. 1877-1883.
  • 2006. Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes. Virchows Archiv. 788-796.
  • 2006. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes. 1713-1722.
  • 2006. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes. 1713-1722.
  • 2006. A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes - Studies of HNF4A variants in the Norwegian MODY registry. Diabetes. 1899-1903.
  • 2005. Molekylærgenetisk diagnostikk ved diabetes mellitus. Tidsskrift for Den norske legeforening. 2968-72.
  • 2005. Molekylærgenetisk diagnostikk ved diabetes mellitus. Tidsskrift for Den norske legeforening. 2968-2972.
  • 2005. Functional dissection of the HNF-1alpha transcription factor: A study on nuclear localization and transcriptional activation. DNA and Cell Biology. 661-669.
  • 2005. Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus. Diabetic Medicine. 1012-1015.
  • 2005. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. Journal of Investigative Dermatology. 312-317.
  • 2005. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes, Chromosomes and Cancer. 10-18.
  • 2004. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2 - Patient characteristics and initial response to sulfonylurea therapy. Diabetes. 2713-2718.
  • 2004. G protein-coupled receptor agonist-stimulated expression of ATF3/LRF-1 and c-myc and comitogenic effects in hepatocytes do not require EGF receptor transactivation. Journal of Cellular Physiology. 349-358.
  • 2004. G protein-coupled receptor agonist-stimulated expression of ATF3/LRF-1 and c-myc and comitogenic effects in hepatocytes do not require EGF receptor transactivation. Journal of Cellular Physiology. 349-358.
  • 2004. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 221-227.
  • 2004. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Molecular Psychiatry. 621-629.
  • 2003. Permanent neonatal diabetes mellitus due to glucokinase deficiency- an inborn error of the glucose-insulin signalling pathway. Diabetes. 2854-2860.
  • 2003. Permanent neonatal diabetes caused by glucokinase deficiency; inborn error of the glucose-insulin signaling pathway. Diabetes. 2854-2860.
  • 2003. Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway. Journal of Clinical Endocrinology and Metabolism. 920-931.
  • 2003. Hepatocyte nuclear factor- 1 alpha gene mutations and diabetes in Norway. Journal of Clinical Endocrinology and Metabolism. 920-931.
  • 2003. Forskere diskuterte diabetes. Diabetes for helsepersonell. 12-14.
  • 2003. Examination of IMPA1- and IMPA2 genes in manic-depressive patients: Association between IMPA2 promoter polymorphisms and bipolar disorder. Molecular Psychiatry. Epub-23Dec2003.
  • 2003. Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects? Pharmacogenetics (London). 383-388.
  • 2003. Association between blood carisoprodol/meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: Decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects? Pharmacogenetics (London). 383-388.
  • 2003. Association between blood carisoprodol/meprobamate concentration ratios and CYP2C19 genotype in carisoprodol drugged drivers: Decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects? Pharmacogenetics (London). 383-388.
  • 2002. Hunting for a hypoglyecemia gene:Severe neonatal hypoglyecemia in a consanguineuos family. American Journal of Medical Genetics. 40-46.
  • 2001. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism? Pharmacogenetics (London). 45-55.
  • 2001. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism? Pharmacogenetics (London). 45-55.
  • 2001. Permanent neonatal diabetes mellitus due to complete glucoinase deficiency. New England Journal of Medicine. 1588-1592.
  • 2001. N EONATAL D IABETES M ELLITUS D UE TO C OMPLETE G LUCOKINASE D EFICIENCY. New England Journal of Medicine. 1588-1592.
  • 2001. MODY-prosjektet ved Haukeland Sykehus: fra forskning til diagnostikk. Diabetes for helsepersonell. 23-24.
  • 2000. MODY associated with two novel hepatocyte nuclear factor 1 alpha loss of function mutations. Biochemical and Biophysical Research Communications - BBRC. 792-798.
  • 2000. MGM - Medisin, Gener og Mennesker. NBS-nytt. 25-27.
  • 2000. A simple test for the hot spot mutation P291fsinsC in MODY3. Diabetologia. 818-819.
  • 2000. A human myoinositol monophosphatase gene (IMPA2) localized in a susc eptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Molecular Psychiatry. 172-180.
  • 2000. A human myoinositol monophosphatase gene (IMPA2) localized in a susc eptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Molecular Psychiatry.
  • 1999. Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1). Pharmacogenetics (London). 517-528.
  • 1997. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA). Genomics. 113-122.
  • 1997. Gap junctions and growth control in liver regeneration and in isolated rat hepatocytes. Hepatology. 847-855.
  • 1997. Gap junctions and growth control in liver regeneration and in isolated rat hepatocytes. Hepatology. 847-855.
  • 1997. Forfatterskap til besvær. Klinisk Biokemi i Norden. 7-10.
  • 1996. Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Letters. 30-34.
  • 1996. Ultrarapid metabilizers of debrisoquine : characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Letters. 30-34.
  • 1996. Priser til begjær -del II. NBS-nytt. 20-21.
  • 1996. Priser til begjær (og #/en til besvær). NBS-nytt. 21-22.
  • 1996. Fusk og fanteri i forskningen. NBS-nytt. 16-22.
  • 1996. Fargerik forskar fyller femti. NBS-nytt. 20-21.
  • 1996. Chromosomal assignment of the human gene encoding the Fos-related antigen-2 (FRA-2) to chromosome 2p22-p23. Genomics. 72-75.
  • 1996. Chromosomal assignment of the human gene encoding the Fos-related antigen-2 (FRA-2) to chromosome 2p22-p23. Genomics. 72-75.
  • 1996. A retroviral element in the human CYP2D gene cluster. Pharmacogenetics (London). 375-377.
  • 1995. Uracil-DNA-glykosylase - en norsk suksesshistorie. NBS-nytt. 40-44.
  • 1995. Protein-folding med konsekvensar. Om scrapie, prionar og degenerative hjernesjukdomar. NBS-nytt. 12-15.
  • 1995. Med Goksøyr inn i genalderen. NBS-nytt. 23-24.
  • 1995. Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of the human cytochrome P450 CYP2D6 gene. Hum Molecul Genet. 2251-2257.
  • 1995. Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene. Human Molecular Genetics. 2251-2257.
  • 1995. Conserved sequence patterns in phages Mu and Lambda. Biochimica et Biophysica Acta. 115-120.
  • 1995. Conserved sequence patterns in phages Mu and Lambda. Biochimica et Biophysica Acta. 115-120.
  • 1995. Apoptose - når cellene dør. Naturen. 18-26.
  • 1995. Aarskog-genet endelig klonet. NBS-nytt. 12-13.
  • 1992. The zebrafish homeobox gene Hox(zf-114): primary structure, expression pattern and evolutionary aspects. International Journal of Developmental Biology. 229-237.
  • 1992. Structure and early embryonic expression of the zebrafish engrailed-2 gene. Mechanisms of Development. 51-62.
  • 1991. Genomic structure and restricted neural expression of the zebrafish wnt-1 (int-1) gene. EMBO Journal. 799-807.
Vitenskapelig foredrag
  • 2004. PI3K/Akt signalveien ved livmorhalskreft.
  • 2004. HRAS, KRAS, NRAS and BRAF mutation analysis in oral squamous cell carcinomas from the Sudan.
  • 2003. Mutation analysis of the RAS-RAF pathway in pancreatic adenocarcinomas and malignant melanomas.
  • 2003. BRAF mutational analysis in oral dysplastic and neoplastic epithelial lesions.
  • 2001. Autosomal recessive glucagon deficiency and severe neonatal hypoglycemia: A candidate gene approach.
  • 1999. Searching for genetic variations in inositol monophosphatase genes in lithium-treated manic-depressive patients.
  • 1999. Molecular genetic analyses of Norwegian families with maturity-onset diabetes of the young.
  • 1999. Maturity onset diabetes of the young (MODY): A Norwegian experience.
  • 1998. Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1).
  • 1998. Genomic characterization of genes encoding human myo-inositol monophosphatase enzymes.
  • 1998. Gene mutations of the phosphatidylinositol signaking system in lithium-treated manic-depressive patients.
Kronikk
  • 1996. Nytt DNA-sekvenseringslaboratorium opna i Bergen. NBS-nytt. 22.
  • 1995. Nobelprisen i fysiologi og medisin 1995 - fosterutviklingens mysterium. Tidsskrift for Den norske legeforening. 3712-3713.
Sammendrag/abstract
  • 2016. Ultrasound and microbubble enhanced treatment of inoperable pancreatic adeonocarcinoma. Journal of Clinical Oncology.
  • 2013. Detection of B-Cell Lymphoma in Bone Marrow Aspirates Using BIOMED-2 Immunoglobulin Primers. Laboratory Investigation. 320A-320A.
  • 2013. Detection of B-Cell Lymphoma in Bone Marrow Aspirates Using BIOMED-2 Immunoglobulin Primers. Modern Pathology. 320A-320A.
  • 2013. Cellular re-uptake of secreted carboxyl-ester lipase protein in CEL-MODY, a syndrome of diabetes and pancreatic exocrine dysfunction. Diabetologia. S152-S152.
  • 2010. Evaluation of BIOMED-2 PCR primers for detection of clonality in follicular lymphoma on formalin-fixed, paraffin-embedded samples. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 252-253.
  • 2009. The Genotypes and Phenotypes of Diabetes. Journal of the Pancreas.
  • 2009. Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes. Journal of Medical Genetics. S26-S26.
  • 2009. Evaluation of BIOMED-2 PCR primers for detection of clonality in follicular lymphoma on formalin-fixed, paraffin-embedded samples. Virchows Archiv. 395-395.
  • 2008. The role of confirmed type 2 diabetes risk alleles on age-of-diagnosis in a Norwegian population based sample: the HUNT Study. Diabetologia. S129-S129.
  • 2008. Structural changes in the repeated region of the carboxyl-ester lipase (CEL) gene and the development of diabetes. Diabetologia. S123-S123.
  • 2008. SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group. Diabetologia. S116-S116.
  • 2008. Pancreatic exocrine dysfunction in diabetes: functional characterisation of the carboxyl-ester lipase gene. Diabetologia. S123-S124.
  • 2008. Congenital Hyperinsullnism: Prevalence Prevalence of activating glucokinase mutations and a novel mutation. Hormone Research. 41-41.
  • 2007. Pancreatic exocrine deficiency is common in MODY 3. Diabetologia. S123-S123.
  • 2006. AKT phosphorylation and PIK3CA amplification are common in cervical neoplasia. Laboratory Investigation. 172A-172A.
  • 2006. AKT phosphorylation and PIK3CA amplification are common in cervical neoplasia. Modern Pathology. 172A-172A.
Vitenskapelig oversiktsartikkel/review
  • 2018. The role of the carboxyl ester lipase (CEL) gene in pancreatic disease. 12-19.
  • 2015. The chromosome 9p21 CVD- and T2D-associated regions in a Norwegian population (the HUNT2 survey). 9 sider.
  • 2012. The role of pancreatic imaging in monogenic diabetes mellitus. 148-159.
  • 2011. Role of molecular genetics in transforming diagnosis of diabetes mellitus. 313-320.
  • 2010. Fremskritt innen diabetesgenetikk. 1145-1149.
  • 2006. Forstadier til kreft i bukspyttkjertelen. 905-908.

Se fullstendig oversikt over publikasjoner i CRIStin.

For vitenskapelige publikasjoner, se også her.